Tessera Therapeutics Company
In recent years, we’ve made extraordinary leaps in genetic medicine, with two pillar technologies emerging: gene therapy and gene editing. While these methods represent major advancements, they are not without significant limitations.
Technology:
Others
Funding Status:
Series B
Number Of Exists:
11-50
Investor Type:
Early Stage Venture
Investors Number:
6
Employee Number:
11-50
Last Funding Date:
Jan 12, 2021
Headquarters:
Cambridge, Massachusetts, United States
Last Funding Type:
Series B
Total Funding:
230M
Founded Date:
2018
Industry:
Biopharma, Biotechnology, Gene therapy, Therapeutics